Next Article in Journal
A Comprehensive Review on the Chemical Constituents and Functional Uses of Walnut (Juglans spp.) Husk
Next Article in Special Issue
Glucose Restriction Plus Refeeding in Vitro Induce Changes of the Human Adipocyte Secretome with an Impact on Complement Factors and Cathepsins
Previous Article in Journal
Epigenetic Regulation of Adipogenic Differentiation by Histone Lysine Demethylation
Previous Article in Special Issue
Expression of Chemerin and Its Receptors in the Porcine Hypothalamus and Plasma Chemerin Levels during the Oestrous Cycle and Early Pregnancy
 
 
Article
Peer-Review Record

Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma

Int. J. Mol. Sci. 2019, 20(16), 3919; https://doi.org/10.3390/ijms20163919
by Susanne Feder 1, Arne Kandulski 1, Doris Schacherer 1, Thomas S. Weiss 2 and Christa Buechler 1,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2019, 20(16), 3919; https://doi.org/10.3390/ijms20163919
Submission received: 31 July 2019 / Revised: 9 August 2019 / Accepted: 10 August 2019 / Published: 12 August 2019
(This article belongs to the Special Issue Adipokines 2.0)

Round 1

Reviewer 1 Report

This is a second version of article entitled: “Serum chemerin does not differentiate colorectal liver metastases from hepatocellular carcinoma”.  

All my previous remarks for this article were corrected by authors.

Author Response

All my previous remarks for this article were corrected by authors.

Thank you again for your valuable comments which were very helpful to improve the manuscript.

Reviewer 2 Report

The manuscript has been improved after the first revision. But other minor comments:

The new data introduced in table 1 gives new information. It should be interesting to introduce reference values for Prothrombin time, bilirubin, ALT, AST or GGT.

Line 86-89: the letters are in italics.

Line 105: I would delete the word surprisingly.

Figure 3: I don’t understand the number scale of spider diagram. What is refers to?

Line 317: What wavelength was used to read the Elisa?

Line 303: Did the authors consider that the time of preservation of serum (collected in 2008) could affect the results of the study?

Author Response

We thank the reviewer for the careful reading of our submission and the very helpful and important comments.

The new data introduced in table 1 gives new information. It should be interesting to introduce reference values for Prothrombin time, bilirubin, ALT, AST or GGT.

We included this information in the figure legend

“Reference values for ALT and AST: < 35 U/l for females and < 50 U/l for males, for bilirubin: 0.2 - 1.4 mg/dl, for GGT: < 40 U/l for females and < 60 U/l for males, for prothrombin time: < 70%.“

We also had to correct in the table that prothrombin time is given in % and not s.

Line 86-89: the letters are in italics.

This was corrected.

Line 105: I would delete the word surprisingly.

105 is now line 111, word was removed.

Figure 3: I don’t understand the number scale of spider diagram. What is refers to?

The spider diagram shows the respective median values on a logarithmic scale. This was included in the figure legend.

Line 317: What wavelength was used to read the Elisa?

Please see 4.2.

„Absorbance was measured at 450 nm, with the correction wavelength set at 540.“

Line 303: Did the authors consider that the time of preservation of serum (collected in 2008) could affect the results of the study?

Thank you for this important information. In the literature we found one paper analyzing chemerin before and 18 months after surgery.

“ Thirty-two obese patients undergoing bariatric surgery were tested before and on an average of 18 months after gastric banding or gastric bypass surgery.“ (DOI: 10.1111/j.1365-2362.2010.02255.x).

 

This group did not report on any differences on chemerin upon storage.

However, we stored serum much longer and there are no data in the literature.

We stored serum at -80°C and avoided freeze-thaw cycles

We now analyzed serum of CRC patients obtained in 2012, 2013, 2014 and 2015. Levels did not differ in 2012 and 2015 and this also indicates that storage time may not grossly affect serum chemerin.

Mehrfachvergleiche

Abhängige Variable:   Chemerin  

Bonferroni

(I) Jahr

(J) Jahr

Mittlere Differenz (I-J)

Std.-Fehler

Signifikanz

95%-Konfidenzintervall

Untergrenze

Obergrenze

12,00

13,00

-80,26350

29,61388

,064

-163,5479

3,0209

14,00

-22,15529

25,02829

1,000

-92,5434

48,2329

15,00

16,62650

26,48746

1,000

-57,8653

91,1183

13,00

12,00

80,26350

29,61388

,064

-3,0209

163,5479

14,00

58,10821

25,02829

,161

-12,2799

128,4964

15,00

96,89000*

26,48746

,005

22,3982

171,3818

14,00

12,00

22,15529

25,02829

1,000

-48,2329

92,5434

13,00

-58,10821

25,02829

,161

-128,4964

12,2799

15,00

38,78179

21,23721

,463

-20,9445

98,5081

15,00

12,00

-16,62650

26,48746

1,000

-91,1183

57,8653

13,00

-96,89000*

26,48746

,005

-171,3818

-22,3982

14,00

-38,78179

21,23721

,463

-98,5081

20,9445

*. Die Differenz der Mittelwerte ist auf dem Niveau 0.05 signifikant.

 

We added this paragraph in 4.1.

 

“Aliquots of the sera were stored at -80 °C and freeze-thaw cycles were avoided. It is important to note that serum storage time differed for up to 7 years. This is a limitation of our study. There was no difference in serum chemerin of patients with CRC collected in 2012 (6 patients) and 2015 (10 patients; p = 0.1). This suggests that a four year storage period at -80°C did not grossly affect serum chemerin levels. Chemerin levels may decline during 7 year storage but this effect may be rather small. “

Back to TopTop